Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Medtronic
Merck
Chubb
Colorcon
Baxter
Accenture
Citi
Harvard Business School

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017442

« Back to Dashboard
NDA 017442 describes MINIPRESS, which is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. Additional details are available on the MINIPRESS profile page.

The generic ingredient in MINIPRESS is prazosin hydrochloride. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.

Summary for NDA: 017442

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Genitourinary Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 017442

Mechanism of ActionAdrenergic alpha-Antagonists

Suppliers and Packaging for NDA: 017442

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL 017442 NDA Pfizer Laboratories Div Pfizer Inc 0069-4310 0069-4310-71 250 CAPSULE in 1 BOTTLE (0069-4310-71)
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL 017442 NDA Pfizer Laboratories Div Pfizer Inc 0069-4370 0069-4370-71 250 CAPSULE in 1 BOTTLE (0069-4370-71)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 5MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 1MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 2MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 017442

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
MINIPRESS
prazosin hydrochloride
CAPSULE;ORAL017442-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Medtronic
US Army
UBS
Cerilliant
Express Scripts
Baxter
Johnson and Johnson
Julphar
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot